| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |